Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Determine the Dosage of Sugammadex as a Rocuronium Reversal's Agent in Infants Younger Than 24 Months Old

NCT07477132 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT07477132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07477132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Determine the Dosage of Sugammadex as a Rocuronium Reversal's Agent in Infants Younger Than 24 Months Old
Lead sponsor
University Hospital, Caen
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
October 1, 2027
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

curarization, postoperative residual